Author Correction: Multiple sclerosis
- PMID: 30467372
- DOI: 10.1038/s41572-018-0050-3
Author Correction: Multiple sclerosis
Abstract
In the originally published version of this article, in Table 4, Ocrelizumab was incorrectly referred to as an anti-CD25 antibody. This has been corrected in the HTML and PDF versions of the article to an anti-CD20 antibody.
Erratum for
-
Multiple sclerosis.Nat Rev Dis Primers. 2018 Nov 8;4(1):43. doi: 10.1038/s41572-018-0041-4. Nat Rev Dis Primers. 2018. PMID: 30410033 Review.
Publication types
LinkOut - more resources
Full Text Sources
Medical
